Recruiting Low Dose Epcoritamab Plus GemOx in R/R DLBCL NCT07451652 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more Locations Hospital Universitario "Dr. José Eleuterio González" — Monterrey, Nuevo León, Mexico View Trial Details
Active, Not Recruiting Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma NCT07621406 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more Locations The First Affiliated Hospital of Soochow University — Suzhou, Jiangsu, China View Trial Details
Active, Not Recruiting GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma NCT05335018 Conditions Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more Locations Seoul National University Hospital — Seoul, South Korea View Trial Details
